The policy of the United States government is to seek regulatory approaches, consistent with applicable laws, that protect health and the environment while reducing unnecessary regulatory burdens and avoiding unjustifiably inhibiting innovation, stigmatizing new technologies, or creating unnecessary trade barriers [Adapted from the National Strategy for Modernizing the Regulatory System for Biotechnology Products, Product of the Emerging Technologies Interagency Policy Coordination Committee's Biotechnology Working Group (OSTP 2016)]. U.S. agencies are focused on delivering health and environmental protection based on the best available science; establishing transparent, coordinated, predictable, and efficient regulatory practices across agencies; and promoting public confidence in the oversight of the products of biotechnology through clear and transparent public engagement [Adapted from the Task Force on Agriculture and Rural Prosperity Report (USDA 2017)]. U.S. agencies that regulate the products of agricultural biotechnology discuss regulatory approaches presented during the June 2018 OECD Conference on Genome Editing Applications in Agriculture, focusing on plants developed using genome editing.

中文翻译：

---

美利坚合众国农业生物技术产品的创新和监管。

美国政府的政策是寻求符合适用法律的监管方法，以保护健康和环境，同时减少不必要的监管负担，避免不合理地抑制创新，污辱新技术或制造不必要的贸易壁垒[改编自《国家战略》生物技术产品监管体系现代化，新兴技术跨部门政策协调委员会生物技术工作组的产品（OSTP 2016）]。美国机构致力于根据现有最佳科学来提供健康和环境保护；在各机构之间建立透明，协调，可预测和有效的监管实践；通过明确和透明的公众参与提高公众对生物技术产品监管的信心[改编自《农业和农村繁荣工作队报告》（USDA，2017）]。监管农业生物技术产品的美国机构讨论了2018年6月经合组织农业基因组编辑应用会议上提出的监管方法，重点是利用基因组编辑开发的植物。